BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 26360917)

  • 1. Financial and Economic Costs of the Elimination and Eradication of Onchocerciasis (River Blindness) in Africa.
    Kim YE; Sicuri E; Tediosi F
    PLoS Negl Trop Dis; 2015; 9(9):e0004056. PubMed ID: 26360917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control, elimination, and eradication of river blindness: scenarios, timelines, and ivermectin treatment needs in Africa.
    Kim YE; Remme JH; Steinmann P; Stolk WA; Roungou JB; Tediosi F
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003664. PubMed ID: 25860569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of onchocerciasis.
    Boatin BA; Richards FO
    Adv Parasitol; 2006; 61():349-94. PubMed ID: 16735169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis.
    Kastner RJ; Sicuri E; Stone CM; Matwale G; Onapa A; Tediosi F
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005934. PubMed ID: 28949987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards the elimination of onchocerciasis.
    Thylefors B; Alleman M
    Ann Trop Med Parasitol; 2006 Dec; 100(8):733-46. PubMed ID: 17227651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of transmission of onchocerciasis (river blindness) with long-term ivermectin mass drug administration with or without vector control in sub-Saharan Africa: a systematic review and meta-analysis.
    Mutono N; Basáñez MG; James A; Stolk WA; Makori A; Kimani TN; Hollingsworth TD; Vasconcelos A; Dixon MA; de Vlas SJ; Thumbi SM
    Lancet Glob Health; 2024 May; 12(5):e771-e782. PubMed ID: 38484745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Onchocerciasis Elimination Program for the Americas (OEPA).
    Sauerbrey M
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():25-9. PubMed ID: 18718151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of onchocerciasis from Africa: possible?
    Mackenzie CD; Homeida MM; Hopkins AD; Lawrence JC
    Trends Parasitol; 2012 Jan; 28(1):16-22. PubMed ID: 22079526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The onchocerciasis chronicle: from the beginning to the end?
    Crump A; Morel CM; Omura S
    Trends Parasitol; 2012 Jul; 28(7):280-8. PubMed ID: 22633470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
    Tekle AH; Zouré HG; Noma M; Boussinesq M; Coffeng LE; Stolk WA; Remme JH
    Infect Dis Poverty; 2016 Jun; 5(1):66. PubMed ID: 27349645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful elimination of onchocerciasis (river blindness) vectors from isolated foci in two African countries.
    Brattig NW
    Acta Trop; 2009 Sep; 111(3):201-2. PubMed ID: 19619685
    [No Abstract]   [Full Text] [Related]  

  • 12. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
    Diawara L; Traoré MO; Badji A; Bissan Y; Doumbia K; Goita SF; Konaté L; Mounkoro K; Sarr MD; Seck AF; Toé L; Tourée S; Remme JH
    PLoS Negl Trop Dis; 2009 Jul; 3(7):e497. PubMed ID: 19621091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination.
    Alley WS; van Oortmarssen GJ; Boatin BA; Nagelkerke NJ; Plaisier AP; Remme JH; Lazdins J; Borsboom GJ; Habbema JD
    BMC Public Health; 2001; 1():12. PubMed ID: 11734070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modelling the impact of larviciding on the population dynamics and biting rates of Simulium damnosum (s.l.): implications for vector control as a complementary strategy for onchocerciasis elimination in Africa.
    Routledge I; Walker M; Cheke RA; Bhatt S; Nkot PB; Matthews GA; Baleguel D; Dobson HM; Wiles TL; Basañez MG
    Parasit Vectors; 2018 May; 11(1):316. PubMed ID: 29843770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
    Coffeng LE; Stolk WA; Zouré HG; Veerman JL; Agblewonu KB; Murdoch ME; Noma M; Fobi G; Richardus JH; Bundy DA; Habbema D; de Vlas SJ; Amazigo UV
    PLoS Negl Trop Dis; 2013; 7(1):e2032. PubMed ID: 23383355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Onchocerciasis Control Programme in West Africa (OCP).
    Boatin B
    Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():13-7. PubMed ID: 18718148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of onchocerciasis in Ecuador: findings of post-treatment surveillance.
    Guevara Á; Lovato R; Proaño R; Rodriguez-Perez MA; Unnasch T; Cooper PJ; Guderian RH
    Parasit Vectors; 2018 Apr; 11(1):265. PubMed ID: 29690907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of onchocerciasis from Colombia: first proof of concept of river blindness elimination in the world.
    Nicholls RS; Duque S; Olaya LA; López MC; Sánchez SB; Morales AL; Palma GI
    Parasit Vectors; 2018 Apr; 11(1):237. PubMed ID: 29642939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaching the london declaration on neglected tropical diseases goals for onchocerciasis: an economic evaluation of increasing the frequency of ivermectin treatment in Africa.
    Turner HC; Walker M; Churcher TS; Osei-Atweneboana MY; Biritwum NK; Hopkins A; Prichard RK; Basáñez MG
    Clin Infect Dis; 2014 Oct; 59(7):923-32. PubMed ID: 24944228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.